ストックスクリーナーアプリを入手
44.95
2.22%
-1.07
前日終値:
$46.02
開ける：
$45.22
24時間の取引高:
15.33M
Relative Volume:
0.39
時価総額：
$9.78B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
65.14
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
-9.96%
1か月 パフォーマンス:
-10.68%
6か月 パフォーマンス:
-23.08%
1年 パフォーマンス:
+188.83%
1日の値動き範囲:
$44.55
$45.76
1週間の範囲:
$44.55
$48.98
52週間の値動き範囲:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
名前
Hims Hers Health Inc
電話
415-851-0195
住所
2269 CHESTNUT ST, SAN FRANCISCO
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
44.95 | 10.40B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.60 | 361.57B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
61.33 | 149.56B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
84.48 | 68.76B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
131.58 | 44.11B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.10 | 40.68B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
GDRX stock soars 30% today: GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims - Fast Company
Meta's reported shake-up, Hims & Hers sinks on GoodRx–Novo deal - Yahoo Finance
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers (HIMS) Drops Amid Reported Details of FTC - GlobeNewswire
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets - Benzinga
Levi & Korsinsky Releases SueWallSt Podcast on Hims & Hers Health, Inc. (HIMS) Lawsuit - ACCESS Newswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationHIMS - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - MarketScreener
Hims & Hers Health: Legal Storms and the Future of Shareholder Value - AInvest
HIMS DEADLINE REMINDER: Important August 25, 2025 Deadline Reminder in Hims & Hers Health, Inc. Securities Class Action Lawsuit - WV News
Join Class Action to Recover Losses from Hims & Hers Health, Inc. (HIMS)Contact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. InvestorsLead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
CoreWeave, Applied Materials And Hims & Hers Are Among Top 10 Large Cap Losers Last Week (August 11-August 15): Are The Others In Your Portfolio? - Benzinga
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - FinancialContent
HIMS INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - PR Newswire
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by LPL Financial LLC - Defense World
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces - GlobeNewswire
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims - Morningstar
Hims & Hers Health Shares Drop 2.36% on 24.26% Volume Decline Ranking 106th as FTC Probes and Novo Partnership Collapse Weigh - AInvest
Hims & Hers Health's Transformation Into A Precision Health Platform (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Navigating the Post-GLP-1 Landscape – Can Innovation Outpace Regulation? - AInvest
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Hims & Hers HIMS Slides on FTC Probe. What’s Next? - NAI500
Precigen, Twilio, Hims & Hers - TradingView
Levi & Korsinsky Notifies Shareholders of Hims & Hers Health, Inc.(HIMS) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge - Yahoo Finance
Why Is Hims & Hers Stock Falling Friday?Hims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers Faces Scrutiny Over Subscription Cancellations - Finimize
Securities Lawsuit Alert: Hims & Hers Health, Inc. (HIMS)Contact Levi & Korsinsky Before August 25, 2025 - Stockhouse
Hims & Hers Health Under FTC Probe for Cancellation Policies - MarketScreener
Vanguard Group Inc. Has $546.05 Million Stock Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health Plunges 2.48% on $1.11 Billion Volume Ranking 67th Amid FTC Scrutiny Over Cancellation Hurdles - AInvest
GLP-1 Sector Under Scrutiny: Hims & Hers' Crisis and the Future of Investor Trust - AInvest
Hims & Hers Health under investigation by FTC over business practicesreport - Seeking Alpha
HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, - GlobeNewswire
FTC Probing Complaints About Hims’ Cancellation Practices - Bloomberg.com
US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports - Reuters
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) InvestorsLead Plaintiff Deadline on August 25, 2025 - The Globe and Mail
FTC Investigates Hims & Hers Over Subscription Cancellation Complaints - AInvest
Here’s Why Wall Street Is Cautious on Hims & Hers Health Stock (HIMS) - TipRanks
US FTC Investigating Hims & Hers Over Advertising and Cancellation Practices, Bloomberg News Reports - US News Money
US FTC investigating Hims & Hers over advertisements and cancellation practices, Bloomberg News reports - MarketScreener
Shareholders of Hims & Hers Health, Inc. Should Contact - GlobeNewswire
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
HIMS DEADLINE REMINDER: Important August 25, 2025 Deadline - GlobeNewswire
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
4.67%
1.85%
大文字化:
|
ボリューム (24 時間):